Skip to content
ChickenStockChickenStock
ResearchBNTX
Biontech logo

Biontech (BNTX) stock

NASDAQ

$85.60+0.66%(+0.56)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

-16.87x

Net loss — not comparable

P/B

1.00x

P/S

6.67x

Latest earnings

Recent results in a standard quarterly format were not found in SEC filings.

Some foreign companies file only annual or current reports, so quarterly figures may be missing.

See recent SEC filings →

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

26 SEC filings
  • Sahin UgurChief Executive Officer · Oct 9, 2026Open-market sale36,209 shares · $3.5M
    Avg. price $95.37330 shares held after
  • Sahin UgurChief Executive Officer · Oct 8, 2026Open-market sale27,000 shares · $2.5M
    Avg. price $92.314236,209 shares held after
  • Sahin UgurChief Executive Officer · Oct 7, 2026Open-market sale24,000 shares · $2.3M
    Avg. price $95.859763,209 shares held after
  • Sahin UgurChief Executive Officer · Oct 6, 2026Open-market sale21,000 shares · $2.0M
    Avg. price $96.809387,209 shares held after
  • Sahin UgurChief Executive Officer · Oct 5, 2026Open-market sale72,000 shares · $7.0M
    Avg. price $97.2312108,209 shares held after
  • Sahin UgurChief Executive Officer · Oct 2, 2026Open-market sale17,000 shares · $1.6M
    Avg. price $96.7249180,209 shares held after
  • Sahin UgurChief Executive Officer · Oct 1, 2026Open-market sale17,000 shares · $1.7M
    Avg. price $97.4556197,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 30, 2026Open-market sale32,000 shares · $3.1M
    Avg. price $98.1203214,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 29, 2026Open-market sale34,000 shares · $3.3M
    Avg. price $98.2591246,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 28, 2026Open-market sale34,000 shares · $3.3M
    Avg. price $98.4682280,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 25, 2026Open-market sale27,000 shares · $2.7M
    Avg. price $98.6882314,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 24, 2026Open-market sale39,000 shares · $3.9M
    Avg. price $98.9913341,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 23, 2026Open-market sale30,000 shares · $3.0M
    Avg. price $99.4027380,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 22, 2026Open-market sale46,000 shares · $4.6M
    Avg. price $100.7182410,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 21, 2026Open-market sale33,000 shares · $3.2M
    Avg. price $97.8097456,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 18, 2026Open-market sale30,000 shares · $2.9M
    Avg. price $96.2243489,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 17, 2026Open-market sale34,000 shares · $3.4M
    Avg. price $98.5983519,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 16, 2026Open-market sale15,000 shares · $1.4M
    Avg. price $96.0893553,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 15, 2026Open-market sale34,000 shares · $3.3M
    Avg. price $96.4893568,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 14, 2026Open-market sale41,000 shares · $4.1M
    Avg. price $99.4467602,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 11, 2026Open-market sale45,000 shares · $4.4M
    Avg. price $96.9338643,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 10, 2026Open-market sale20,500 shares · $2.0M
    Avg. price $96.3067688,209 shares held after
  • Sahin UgurChief Executive Officer · Sep 9, 2026Open-market sale36,000 shares · $3.5M
    Avg. price $97.7818708,709 shares held after
  • Sahin UgurChief Executive Officer · Sep 8, 2026Open-market sale37,000 shares · $3.7M
    Avg. price $99.2032744,709 shares held after
  • Sahin UgurChief Executive Officer · Sep 4, 2026Open-market sale31,500 shares · $3.3M
    Avg. price $103.5182781,709 shares held after
  • Sahin UgurChief Executive Officer · Sep 3, 2026Open-market sale45,000 shares · $4.6M
    Avg. price $102.8496813,209 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Biontech (BNTX) stock information

NASDAQ

Biontech (BNTX) is listed on NASDAQ. Its market capitalization is about $21.7B. On trailing-twelve-month earnings the P/E ratio is -16.87, and the P/B ratio is 1. Return on equity is -5.9%. These figures are computed in-house from official filings and are reference information only.

Biontech — frequently asked questions

What is the P/E ratio of Biontech (BNTX)?
On a trailing-twelve-month basis, BNTX trades at a P/E ratio of -16.87. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Biontech?
BNTX has a market capitalization of about $21.7B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.